Latest Breaking News On - Amsterdam neuroscience - Page 1 : comparemela.com

Cognition Therapeutics Releases New Episode Of Conversations Podcast: Protecting The Synapse From Amyloid Toxicity In Alzheimer s Disease

PURCHASE, N.Y., May 21, 2024 (GLOBE NEWSWIRE)

Jort vijverbergMary hambyAnthony caggianoAmsterdam alzheimer center at neuroscienceCompany or cognitionCognition therapeutics incHealth care disclaimerAmyloid toxicityCognition therapeuticsStaff neurologistAmsterdam alzheimer centerAmsterdam neuroscienceSpires jonesPersonal chairDeputy directorDiscovery brain sciences

Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer s Disease on April 12, 2024 -April 01, 2024 at 07:31 am EDT

NEW YORK, April 01, 2024 Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on.

United statesNoord hollandCasey mcdonaldAnton porsteinssonMartinj sadowskiMike moyerJort vijverbergHenrym wisniewskiResearch in drUniversity of amsterdamYork university school of medicineAlzheimer associationAmerican federation for aging researchSchool of medicineCompany or cognitionCognition therapeutics inc

Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022

Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth san franciscoNoord hollandEric hyllengrenSamantha noteboomKiren kresa reahlAlex chapmanAtara biotherapeutics incMs center amsterdamExchange commissionProgressive multiple sclerosis using health recordsSecurities exchangeResearch in multiple sclerosisEuropean committee for treatmentImprovement observedOpen label extension

ATARA Biotherapeutics (ATRA) Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188

ATARA Biotherapeutics (ATRA) Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Biomarkers for Alzheimer s Disease: The Road Towards Clinical Implementation, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) May 16, 2022 Cerebrospinal fluid (CSF) biomarkers for Alzheimer’s disease (AD) have become the cornerstone of the etiological diagnosis

United kingdomNoord hollandPieter van bokhovenCharlotte teunissenHoneycomb worldwide incNeurochemistry labChief scientific officerIndustry alliance officeAmsterdam neuroscienceRoad towards clinicalLife sciencePress release